Literature DB >> 4044740

Improved high-performance liquid chromatographic method for the simultaneous determination of caffeine and its N-demethylated metabolites in plasma using solid-phase extraction.

R Hartley, I J Smith, J R Cookman.   

Abstract

An improved high-performance liquid chromatographic method for the simultaneous determination of caffeine and its N-demethylated metabolites in plasma is described. Excellent resolution of all components is provided by reversed-phase chromatography using a mobile phase consisting of 1% acetic acid-methanol (83:17) at a flow-rate of 2.7 ml/min, in conjunction with a Waters Assoc. Nova-Pak C18 column which was protected by a Waters Assoc. Guard-Pak precolumn module containing a Guard-Pak CN cartridge. Rapid extraction of caffeine and the dimethylxanthines from plasma was achieved using reversed-phase octadecylsilane bonded-silica columns (Bond-Elut C18). With only 100 microliters of sample, plasma levels in the region of 50 ng/ml for the dimethylxanthines and 100 ng/ml for caffeine can be determined using ultraviolet detection at 273 nm. The method has been used for measuring umbilical cord plasma samples to provide information regarding foetal exposure to caffeine and its metabolites and is also suitable for therapeutic drug monitoring of caffeine and theophylline levels in the treatment of neonatal apnoea.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4044740     DOI: 10.1016/s0378-4347(00)84493-x

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Effects of moderate exercise on the pharmacokinetics of caffeine.

Authors:  K Collomp; F Anselme; M Audran; J P Gay; J L Chanal; C Prefaut
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary disease.

Authors:  R C Dockens; D Rapoport; D Roberts; D S Greene; R H Barbhaiya
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

3.  Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption.

Authors:  Peter J Rogers; Christa Hohoff; Susan V Heatherley; Emma L Mullings; Peter J Maxfield; Richard P Evershed; Jürgen Deckert; David J Nutt
Journal:  Neuropsychopharmacology       Date:  2010-06-02       Impact factor: 7.853

4.  Chronic caffeine administration exacerbates renovascular, but not genetic, hypertension in rats.

Authors:  A Ohnishi; R A Branch; K Jackson; R Hamilton; I Biaggioni; G Deray; E K Jackson
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.